|
Buy (2.84 out of 4)
19th percentile
|
|
|
SLIDESHOW: 25 Top Ranked Socially Responsible Dividend Stocks
By ETF Channel Staff, updated Monday, May 13, 10:24 PM
#5. Amgen Inc (NASDAQ:AMGN) — 2.90% Yield Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim). AMGN is found in these ETFs: DSI, more View AMGN's Dividend History at Dividend Channel »
Company Name: |
Amgen Inc |
Website: |
www.amgen.com |
Sector: |
Biotechnology |
Number of ETFs Holding AMGN: |
134 |
Total Market Value Held by ETFs: |
$27.09B |
Total Market Capitalization: |
$167.83B |
% of Market Cap. Held by ETFs: |
16.14% |
|
Open the ETF Channel AMGN Page (in a new window) »
|
|
|